New FDA India boss calls for transparency and collaboration
This article was originally published in Scrip
Executive Summary
Dr Altaf Ahmed Lal's new role as director of the US FDA's India office has been likened to "scaling Mount Everest" - quite appropriately, some observers say, in view of the sheer mountain of domestic sites involved in supplying the US and a recent string of highly publicized GMP-related issues at some leading Indian firms.